Gut

Aims & Scope

Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas.

Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology.

Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	25.8
2024	23.00

Journal Rank

Year	Value
2024	103

Journal Citation Indicator

Year	Value
2024	16121

SJR (SCImago Journal Rank)

Year	Value
2024	8.874

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	364

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus

  Citation: 5244

  Authors: Peter A, Thomas L, Christos, Hein G, Colin D, Michael G, Gregory G, Santhi Swaroop

• Global patterns and trends in colorectal cancer incidence and mortality

  Citation: 3749

  Authors: Melina, Mónica S, Mathieu, Isabelle, Ahmedin, Freddie

• The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

  Citation: 2555

  Authors: J

• Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

  Citation: 2497

  Authors: J H, E W, W J, C P, G T

• The risk of colorectal cancer in ulcerative colitis: a meta-analysis

  Citation: 2335

  Authors: J A

• Management of<i>Helicobacter pylori</i>infection—the Maastricht V/Florence Consensus Report

  Citation: 2308

  Authors: P, F, C A, J P, E J, A T, F, A, J, D Y, R, P, T, M, M, S, K, E M

• Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

  Citation: 2075

  Authors: P. D., S., T., Y., A., O., L., D., A., D. M., G. G., N. M.

• Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

  Citation: 1881

  Authors: C

• The gut microbiota and host health: a new clinical frontier

  Citation: 1855

  Authors: Julian R, David H, Francesca, Gerben D A, Gideon M, Georgina, Mohammed Nabil, James, Hauke, Kieran M, Linda V, Erwin G, Ailsa

• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

  Citation: 1852

  Authors: Christopher Andrew, Nicholas A, Tim, Philip Anthony, Philip J, Jimmy K, Bu’Hussain, Miranda C E, Gareth C, Christian, Kevin J, R Justin, Cathy, Stuart, Malcolm G, Omar, Aileen, Vikki, Paul D, Miles, Jeremy, Helen, Daniel R, Tariq H, Stuart A, Melissa, Matthew, Richard, A Barney

---